Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

0.3000
-0.0240-7.41%
Volume:193.29K
Turnover:58.33K
Market Cap:61.80M
PE:-0.05
High:0.3250
Open:0.3250
Low:0.2950
Close:0.3240
Loading ...
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 19, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 22, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Correspondence

Form CORRESP - Correspondence
Feb 08, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 08, 2024

Correspondence

Form CORRESP - Correspondence
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 19, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933